Trials / Completed
CompletedNCT00186407
Autologous Stem Cell Rescue for Primary Amyloidosis
High Dose Chemotherapy and Autologous Stem Cell Rescue for Primary Amyloidosis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the role of high dose therapy and autologous hematopoietic cell transplant for amyloidosis.
Detailed description
To learn about the use of high dose chemotherapy followed by transplantation using peripheral blood stem cells.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | high dose chemo then auto hematopoietic cell transplant |
Timeline
- Start date
- 1998-04-01
- Primary completion
- 2008-02-01
- Completion
- 2010-02-01
- First posted
- 2005-09-16
- Last updated
- 2010-09-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00186407. Inclusion in this directory is not an endorsement.